Cancer metastasis reviews
Cancer and Metastasis Reviews is a Springer review journal on how cancers grow, spread and resist treatment, and on the biology behind new therapies. Read by researchers who want authoritative overviews rather than primary data.
Overview
Cancer and Metastasis Reviews (catalogued by NLM as Cancer Metastasis Reviews) is a quarterly Springer review journal founded in 1982, originally with Martinus Nijhoff; its founding editors are listed as Isaiah J. Fidler, Garth L. Nicolson and George Poste. It aims to highlight recent significant advances in basic, translational and clinical cancer research, emphasising studies with high impact for the control of cancer. Topics named on its aims page include oncogenes and tumour suppressors, cell death regulation, DNA repair, immune defects, the microbiome, cell metabolism, genetic and epigenetic alterations, the tumour microenvironment, targeted therapies and immunotherapies, biomarkers, early detection technologies and cancer disparities. It is a hybrid journal with open access funding options. Indexed in MEDLINE.
Pages like this
not linked directly; found by shared links- JournalClinical & experimental metastasis
Shares Metastasis, Hallmark: activating invasion and metastasis, PubMed & Europe PMC.
- TermInvasive
Shares Metastasis, Hallmark: activating invasion and metastasis.
- TermDisseminated tumour cells (DTCs)
Shares Metastasis, Hallmark: activating invasion and metastasis.
- PathwayTumour dormancy
Shares Metastasis, Hallmark: activating invasion and metastasis.
- PathwayThe metastatic cascade
Shares Metastasis, Hallmark: activating invasion and metastasis.
- TermOligometastatic disease
Shares Metastasis, Hallmark: activating invasion and metastasis.